Efficacy of sorafenib, molecular targeting drug, for advanced hepatocellular carcinoma
Kuzuya, T.; Tsuchiya, K.; Izumi, N.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1883-1886
2010
ISSN/ISBN: 0385-0684 PMID: 21069944 Document Number: 645508
Document emailed within 1 workday
Related Documents
Li, J.; Wang, L.; Cong, N.; Shi, C.; Bu, W.; Song, J.; Chen, H. 2014: Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors Hepato-Gastroenterology 61(132): 954-957Luo, X.-n.; Lu, L.-g.; Shao, P.-j.; Hu, B.-s.; Li, Y.; Yu, X.-y.; He, X. 2012: Relationship between sorafenib-associated hand-food skin reaction and efficacy in treatment of advanced hepatocellular carcinoma Zhonghua Yi Xue Za Zhi 92(13): 889-893
Shiozawa, K.; Watanabe, M.; Ikehara, T.; Matsukiyo, Y.; Kogame, M.; Okano, N.; Kikuchi, Y.; Igarashi, Y.; Sumino, Y. 2015: Efficacy of Sorafenib versus Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(8): 953-956
Huang, W.; You, L.; Liu, D.; Yang, S.; Liu, M.; Wang, H.; Wang, P.; Baikere, P.; Gu, P.; Abulikemu, A.; Yuan, S.; Fan, X. 2016: S-1 plus sorafenib for the treatment of advanced hepatocellular carcinoma Journal of BUON: Official Journal of the Balkan Union of Oncology 21(6): 1388-1393
Yokoo, H.; Kamiyama, T.; Kakisaka, T.; Orimo, T.; Wakayama, K.; Shimada, S.; Tsuruga, Y.; Kamachi, H.; Taketomi, A. 2015: Efficacy of Sorafenib for Extrahepatic Recurrence of Hepatocellular Carcinoma after Liver Resection Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1497-1499
Natori, T.; Yamaguchi, M. 2013: Complete response after sorafenib therapy plus zoledronic acid for advanced hepatocellular carcinoma with bone metastasis - a case report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(5): 635-637
Shiozawa, K.; Watanabe, M.; Ikehara, T.; Kogame, M.; Matsui, T.; Okano, N.; Kikuchi, Y.; Nagai, H.; Ishii, K.; Makino, H.; Igarashi, Y.; Sumino, Y. 2014: Comparison of Sorafenib and Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Study Hepato-Gastroenterology 61(132): 885-891
Zhang, L.; Ren, Z.-g.; Gan, Y.-h.; Wang, Y.-h.; Zhang, B.-h.; Chen, Y.; Xie, X.-y.; Ge, N.-l.; Ye, S.-l. 2010: Therapeutic efficacy and prognostic factors of sorafenib treatment in patients with unresectable primary hepatocellular carcinoma Zhonghua Zhong Liu Za Zhi 32(8): 630-633
Tang, B.; Chi, Z.; Sheng, X.; Cui, C.; Si, L.; Kong, Y.; Li, S.; Mao, L.; Lian, B.; Wang, X.; Yan, X.; Guo, J. 2015: Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma Zhonghua Yi Xue Za Zhi 95(30): 2459-2461
Tsukamoto, T.; Kanazawa, A.; Shimizu, S.; Murata, A.; Sakae, M.; Kurihara, S.; Tashima, T.; Deguchi, S.; Nakai, T.; Kawasaki, Y.; Kioka, K. 2015: Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1878-1880
Suchánková, G.; Spicák, J. 2011: Sorafenib in the treatment of hepatocellular carcinoma Vnitrni Lekarstvi 57(5): 485-490
Gafton, B.; Porumb, V.; Ungurianu, S.; Marinca, M.V.; Cocea, C.; Croitoru, A.; Balan, G.; Miron, N.; Eliade Ciuleanu, T.; Miron, L. 2014: Hepatocellular carcinoma: insights in the biological treatment beyond sorafenib Journal of Buon: Official Journal of the Balkan Union of Oncology 19(4): 858-866
Shiozawa, K.; Watanabe, M.; Takenaka, H.; Nagai, H.; Ishii, K.; Sakai, K.; Sumino, Y. 2010: Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report Hepato-Gastroenterology 57(101): 688-690
Antoniou, E.A.; Margonis, G.A.; Amini, N.; Anastasiou, M.; Angelou, A.; Kim, Y.; Kouraklis, G. 2016: Sorafenib as an adjuvant therapy for resectable hepatocellular carcinoma: a single center experience Journal of Buon: Official Journal of the Balkan Union of Oncology 21(5): 1189-1194
Kitada, N.; Kanamori, K.; Konishi, A.; Tanaka, S.; Suginoshita, Y.; Inokuma, T.; Hashida, T. 2013: Analysis of factors affecting the duration of treatment with sorafenib in patients with hepatocellular carcinoma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(4): 479-482
Shuto, T.; Murakami, M.; Shimizu, J.; Koga, C.; Yasuyama, A.; Matsumura, T.; Kameda, C.; Kawabata, R.; Hirota, M.; Yoshikawa, M.; Noura, S.; Hasegawa, J. 2016: Treatment Experience with Sorafenib for Lung Metastases of Hepatocellular Carcinoma Complicated with Interstitial Pneumonia Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(12): 1582-1584
Huang, T.; Song, X-shuang.; Zhang, Z-wei. 2013: Efficacies of sorafenib plus interferon in advanced renal cell carcinoma: a report of 57 cases Zhonghua Yi Xue Za Zhi 93(24): 1903-1905
Chen, J.; Xi, W.; Wu, B.; Yu, H.; Chen, S. 2014: Clinical observation of transcatheter arterial chemoembolization plus sorafenib in the treatment of hepatocellular carcinoma with portal vein tumor thrombosis Zhonghua Yi Xue Za Zhi 94(33): 2566-2569
Kitade, H.; Yanagida, H.; Yokoigawa, N.; Yamada, M.; Hijikawa, T.; Kaibori, M.; Matsui, K.; Ishizaki, M.; Yoshioka, K.; Kon, M. 2015: Two Patients with Recurrence of Hepatocellular Carcinoma after Liver Resection Who Achieved Long-Term Stable Disease with Small Doses of Sorafenib Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(7): 863-865
Ikeya, S.; Takayasu, K.; Muramatsu, Y.; Moriyama, N.; Hasegawa, H.; Hirohashi, S. 1990: Evaluation of the efficacy of oil chemoembolization for hepatocellular carcinoma by computed tomography: a proposal for altering the criteria to indicate the efficacy Gan no Rinsho. Japan Journal of Cancer Clinics 36(9): 985-992